Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Taber

Showing results (141-150 of 209) with videos related to

Pageof 21
Sort By:
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 19, 2017
Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot studyJames N Fleming, David J Taber, Nicole A Weimert, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|July 19, 2012
Graft outcomes in pediatric kidney transplantation: focus on the role of raceIbrahim F Shatat, David J Taber, Sheetal Shrivastava, et al.
Transplantation Proceedings|May 22, 2021
Impact of Anesthesiologist Experience on Early Outcomes in Adult Orthotopic Liver TransplantationWilliam D Stoll, Robert A Mester, James N Fleming, et al.
Transplantation|December 24, 2005
Does bioequivalence between modified cyclosporine formulations translate into equal outcomes?David J Taber, G Mark Baillie, Elizabeth E Ashcraft, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 23, 2002
Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipientsDavid J Taber, Robert E Dupuis, Amy L Fann, et al.
Spine|October 7, 2022
Opioid Use Patterns in a Statewide Adult Medicaid Population Undergoing Elective Lumbar Spine SurgeryCharles A Reitman, Ralph Ward, David J Taber, et al.
Hypertension (Dallas, Tex. : 1979)|July 13, 2016
Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant RecipientsDavid J Taber, Kelly J Hunt, Cory E Fominaya, et al.
Clinical Transplantation|August 29, 2019
Protocol-based nurse coordinator management of ambulatory tacrolimus dosing in de novo renal transplant recipients-A single-center experience with a large African American populationZana Elmaasarani, Caitlin Mardis, Logan Gylten, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 22, 2012
The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplantDavid J Taber, Nicole A Pilch, Holly B Meadows, et al.
Clinical Transplantation|September 3, 2013
Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithmKenneth D Chavin, David J Taber, Melissa Norcross, et al.
Pageof 21

Showing results (141-150 of 209) with videos related to

Sort By:
Pageof 21
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 19, 2017
Valganciclovir (VGCV) followed by cytomegalovirus (CMV) hyperimmune globulin compared to VGCV for 200 days in abdominal organ transplant recipients at high risk for CMV infection: A prospective, randomized pilot studyJames N Fleming, David J Taber, Nicole A Weimert, et al.
Saudi Journal of Kidney Diseases and Transplantation : an Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia|July 19, 2012
Graft outcomes in pediatric kidney transplantation: focus on the role of raceIbrahim F Shatat, David J Taber, Sheetal Shrivastava, et al.
Transplantation Proceedings|May 22, 2021
Impact of Anesthesiologist Experience on Early Outcomes in Adult Orthotopic Liver TransplantationWilliam D Stoll, Robert A Mester, James N Fleming, et al.
Transplantation|December 24, 2005
Does bioequivalence between modified cyclosporine formulations translate into equal outcomes?David J Taber, G Mark Baillie, Elizabeth E Ashcraft, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 23, 2002
Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipientsDavid J Taber, Robert E Dupuis, Amy L Fann, et al.
Spine|October 7, 2022
Opioid Use Patterns in a Statewide Adult Medicaid Population Undergoing Elective Lumbar Spine SurgeryCharles A Reitman, Ralph Ward, David J Taber, et al.
Hypertension (Dallas, Tex. : 1979)|July 13, 2016
Impact of Cardiovascular Risk Factors on Graft Outcome Disparities in Black Kidney Transplant RecipientsDavid J Taber, Kelly J Hunt, Cory E Fominaya, et al.
Clinical Transplantation|August 29, 2019
Protocol-based nurse coordinator management of ambulatory tacrolimus dosing in de novo renal transplant recipients-A single-center experience with a large African American populationZana Elmaasarani, Caitlin Mardis, Logan Gylten, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|December 22, 2012
The impact of cardiovascular disease and risk factor treatment on ethnic disparities in kidney transplantDavid J Taber, Nicole A Pilch, Holly B Meadows, et al.
Clinical Transplantation|September 3, 2013
Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithmKenneth D Chavin, David J Taber, Melissa Norcross, et al.
Pageof 21